These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 39212391

  • 1. [Mechanism of HOXC6 promoting the progression of prostate cancer by activating the SFRP1/Wnt/β-catenin signaling pathway].
    Zheng YJ, Li WM, Zheng LC, Zhou YF, Wang J, Xia WM, Ye WJ, Yu JS.
    Zhonghua Nan Ke Xue; 2024 Jul; 30(7):579-587. PubMed ID: 39212391
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt/β-catenin signaling.
    Zhang H, Sun D, Qiu J, Yao L.
    Acta Biochim Pol; 2019 Nov 26; 66(4):393-400. PubMed ID: 31770484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin - Wnt/β-catenin crosstalk.
    Donmez C, Konac E.
    Gene; 2022 Aug 20; 836():146680. PubMed ID: 35738443
    [Abstract] [Full Text] [Related]

  • 12. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, Franco OE, Hayward SW, Cunha GR, Marker PC.
    Cancer Res; 2005 Nov 15; 65(22):10423-30. PubMed ID: 16288033
    [Abstract] [Full Text] [Related]

  • 13. HOXC6 in the prognosis of prostate cancer.
    Zhou J, Yang X, Song P, Wang H, Wang X.
    Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):2715-2720. PubMed ID: 31271305
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.
    Zheng L, Sun D, Fan W, Zhang Z, Li Q, Jiang T.
    PLoS One; 2015 Dec 15; 10(2):e0118276. PubMed ID: 25719802
    [Abstract] [Full Text] [Related]

  • 15. HomeoboxC6 promotes metastasis by orchestrating the DKK1/Wnt/β-catenin axis in right-sided colon cancer.
    Qi L, Chen J, Zhou B, Xu K, Wang K, Fang Z, Shao Y, Yuan Y, Zheng S, Hu W.
    Cell Death Dis; 2021 Apr 01; 12(4):337. PubMed ID: 33795652
    [Abstract] [Full Text] [Related]

  • 16. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
    Li Q, Ye L, Guo W, Wang M, Huang S, Peng X.
    J Exp Clin Cancer Res; 2017 Jun 23; 36(1):85. PubMed ID: 28645312
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R.
    J Cancer Res Clin Oncol; 2020 May 23; 146(5):1153-1167. PubMed ID: 32189106
    [Abstract] [Full Text] [Related]

  • 18. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM, Xiao YS, Wei L, Zhang JQ, Peng CH.
    J Cell Biochem; 2018 Jul 23; 119(7):5308-5323. PubMed ID: 29274277
    [Abstract] [Full Text] [Related]

  • 19. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway.
    Wu F, Li J, Guo N, Wang XH, Liao YQ.
    Am J Cancer Res; 2017 Jul 23; 7(3):405-416. PubMed ID: 28401000
    [Abstract] [Full Text] [Related]

  • 20. MTF2 facilitates the advancement of osteosarcoma through mediating EZH2/SFRP1/Wnt signaling.
    Hu X, Liu Y, Shen H, Zhang T, Liang T.
    J Orthop Surg Res; 2024 Aug 08; 19(1):467. PubMed ID: 39118123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.